ChemoCentryx, Inc. (CCXI)
(Delayed Data from NSDQ)
$12.93 USD
+0.14 (1.09%)
Updated May 3, 2019 04:00 PM ET
After-Market: $12.92 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For CCXI
-
Why Is ChemoCentryx (CCXI) Up 1.4% Since Last Earnings Report?
-
ChemoCentryx (CCXI) Q1 Earnings and Sales Miss Estimates
-
ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates
-
Will ChemoCentryx (CCXI) Report Negative Q1 Earnings? What You Should Know
-
Why Is ChemoCentryx (CCXI) Up 1.8% Since Last Earnings Report?
-
ChemoCentryx (CCXI) Q4 Earnings and Sales Miss Estimates
-
ChemoCentryx (CCXI) Reports Q4 Loss, Lags Revenue Estimates
-
ChemoCentryx (CCXI) Q3 Loss Narrower Than Expected, Sales Top
-
ChemoCentryx (CCXI) Reports Q3 Loss, Tops Revenue Estimates
-
ChemoCentryx (CCXI) Expected to Beat Earnings Estimates: Should You Buy?
-
ChemoCentryx (CCXI) Up 10.5% Since Last Earnings Report: Can It Continue?
-
ChemoCentryx (CCXI) Q2 Loss Wider Than Expected, Sales Down
-
ChemoCentryx (CCXI) Reports Q2 Loss, Lags Revenue Estimates
-
Analysts Estimate ChemoCentryx (CCXI) to Report a Decline in Earnings: What to Look Out for
-
ChemoCentryx (CCXI) Reports Q1 Loss, Tops Revenue Estimates
-
ChemoCentryx (CCXI) Q4 Loss Wider Than Expected, Sales Miss
-
ChemoCentryx (CCXI) Reports Q4 Loss, Misses Revenue Estimates
-
Why Is ChemoCentryx (CCXI) Up 2% Since Last Earnings Report?
-
ChemoCentryx (CCXI) Reports Wider-Than-Expected Q3 Loss
-
ChemoCentryx (CCXI) Reports Q3 Loss, Lags Revenue Estimates
-
Analysts Estimate ChemoCentryx (CCXI) to Report a Decline in Earnings: What to Look Out for